学术探索
学术期刊
新闻热点
数据分析
智能评审
立即登录
CONCOMITANT ADMINISTRATION OF RECOMBINANT HUMAN INTERLEUKIN-2 AND RECOMBINANT INTERFERON-ALPHA-2A IN CANCER-PATIENTS - A PHASE-I STUDY
被引:91
作者
:
LEE, KH
论文数:
0
引用数:
0
h-index:
0
机构:
UNIV TEXAS,MD ANDERSON HOSP & TUMOR INST,CTR CANC,DEPT CLIN IMMUNOL & BIOL THERAPY,BOX 41,HOUSTON,TX 77030
LEE, KH
TALPAZ, M
论文数:
0
引用数:
0
h-index:
0
机构:
UNIV TEXAS,MD ANDERSON HOSP & TUMOR INST,CTR CANC,DEPT CLIN IMMUNOL & BIOL THERAPY,BOX 41,HOUSTON,TX 77030
TALPAZ, M
ROTHBERG, JM
论文数:
0
引用数:
0
h-index:
0
机构:
UNIV TEXAS,MD ANDERSON HOSP & TUMOR INST,CTR CANC,DEPT CLIN IMMUNOL & BIOL THERAPY,BOX 41,HOUSTON,TX 77030
ROTHBERG, JM
MURRAY, JL
论文数:
0
引用数:
0
h-index:
0
机构:
UNIV TEXAS,MD ANDERSON HOSP & TUMOR INST,CTR CANC,DEPT CLIN IMMUNOL & BIOL THERAPY,BOX 41,HOUSTON,TX 77030
MURRAY, JL
PAPADOPOULOS, N
论文数:
0
引用数:
0
h-index:
0
机构:
UNIV TEXAS,MD ANDERSON HOSP & TUMOR INST,CTR CANC,DEPT CLIN IMMUNOL & BIOL THERAPY,BOX 41,HOUSTON,TX 77030
PAPADOPOULOS, N
PLAGER, C
论文数:
0
引用数:
0
h-index:
0
机构:
UNIV TEXAS,MD ANDERSON HOSP & TUMOR INST,CTR CANC,DEPT CLIN IMMUNOL & BIOL THERAPY,BOX 41,HOUSTON,TX 77030
PLAGER, C
BENJAMIN, R
论文数:
0
引用数:
0
h-index:
0
机构:
UNIV TEXAS,MD ANDERSON HOSP & TUMOR INST,CTR CANC,DEPT CLIN IMMUNOL & BIOL THERAPY,BOX 41,HOUSTON,TX 77030
BENJAMIN, R
LEVITT, D
论文数:
0
引用数:
0
h-index:
0
机构:
UNIV TEXAS,MD ANDERSON HOSP & TUMOR INST,CTR CANC,DEPT CLIN IMMUNOL & BIOL THERAPY,BOX 41,HOUSTON,TX 77030
LEVITT, D
GUTTERMAN, J
论文数:
0
引用数:
0
h-index:
0
机构:
UNIV TEXAS,MD ANDERSON HOSP & TUMOR INST,CTR CANC,DEPT CLIN IMMUNOL & BIOL THERAPY,BOX 41,HOUSTON,TX 77030
GUTTERMAN, J
机构
:
[1]
UNIV TEXAS,MD ANDERSON HOSP & TUMOR INST,CTR CANC,DEPT CLIN IMMUNOL & BIOL THERAPY,BOX 41,HOUSTON,TX 77030
[2]
UNIV TEXAS,MD ANDERSON HOSP & TUMOR INST,CTR CANC,DEPT MED ONCOL,HOUSTON,TX 77030
[3]
HOFFMANN LA ROCHE INC,NUTLEY,NJ 07110
来源
:
JOURNAL OF CLINICAL ONCOLOGY
|
1989年
/ 7卷
/ 11期
关键词
:
D O I
:
10.1200/JCO.1989.7.11.1726
中图分类号
:
R73 [肿瘤学];
学科分类号
:
100214 ;
摘要
:
引用
收藏
页码:1726 / 1732
页数:7
相关论文
共 30 条
[21]
ANTITUMOR-ACTIVITY OF RECOMBINANT-DERIVED INTERFERON-ALPHA IN METASTATIC RENAL-CELL CARCINOMA
QUESADA, JR
论文数:
0
引用数:
0
h-index:
0
机构:
UNIV TEXAS,MD ANDERSON HOSP & TUMOR INST,DEPT UROL,HOUSTON,TX 77030
QUESADA, JR
RIOS, A
论文数:
0
引用数:
0
h-index:
0
机构:
UNIV TEXAS,MD ANDERSON HOSP & TUMOR INST,DEPT UROL,HOUSTON,TX 77030
RIOS, A
SWANSON, D
论文数:
0
引用数:
0
h-index:
0
机构:
UNIV TEXAS,MD ANDERSON HOSP & TUMOR INST,DEPT UROL,HOUSTON,TX 77030
SWANSON, D
TROWN, P
论文数:
0
引用数:
0
h-index:
0
机构:
UNIV TEXAS,MD ANDERSON HOSP & TUMOR INST,DEPT UROL,HOUSTON,TX 77030
TROWN, P
GUTTERMAN, JU
论文数:
0
引用数:
0
h-index:
0
机构:
UNIV TEXAS,MD ANDERSON HOSP & TUMOR INST,DEPT UROL,HOUSTON,TX 77030
GUTTERMAN, JU
[J].
JOURNAL OF CLINICAL ONCOLOGY,
1985,
3
(11)
: 1522
-
1528
[22]
QUESADA JR, 1983, CANCER RES, V43, P940
[23]
TREATMENT OF HAIRY-CELL LEUKEMIA WITH RECOMBINANT ALPHA-INTERFERON
QUESADA, JR
论文数:
0
引用数:
0
h-index:
0
机构:
UNIV TEXAS,MD ANDERSON HOSP & TUMOR INST,DEPT PATHOL,HOUSTON,TX 77030
QUESADA, JR
HERSH, EM
论文数:
0
引用数:
0
h-index:
0
机构:
UNIV TEXAS,MD ANDERSON HOSP & TUMOR INST,DEPT PATHOL,HOUSTON,TX 77030
HERSH, EM
MANNING, J
论文数:
0
引用数:
0
h-index:
0
机构:
UNIV TEXAS,MD ANDERSON HOSP & TUMOR INST,DEPT PATHOL,HOUSTON,TX 77030
MANNING, J
REUBEN, J
论文数:
0
引用数:
0
h-index:
0
机构:
UNIV TEXAS,MD ANDERSON HOSP & TUMOR INST,DEPT PATHOL,HOUSTON,TX 77030
REUBEN, J
KEATING, M
论文数:
0
引用数:
0
h-index:
0
机构:
UNIV TEXAS,MD ANDERSON HOSP & TUMOR INST,DEPT PATHOL,HOUSTON,TX 77030
KEATING, M
SCHNIPPER, E
论文数:
0
引用数:
0
h-index:
0
机构:
UNIV TEXAS,MD ANDERSON HOSP & TUMOR INST,DEPT PATHOL,HOUSTON,TX 77030
SCHNIPPER, E
ITRI, L
论文数:
0
引用数:
0
h-index:
0
机构:
UNIV TEXAS,MD ANDERSON HOSP & TUMOR INST,DEPT PATHOL,HOUSTON,TX 77030
ITRI, L
GUTTERMAN, JU
论文数:
0
引用数:
0
h-index:
0
机构:
UNIV TEXAS,MD ANDERSON HOSP & TUMOR INST,DEPT PATHOL,HOUSTON,TX 77030
GUTTERMAN, JU
[J].
BLOOD,
1986,
68
(02)
: 493
-
497
[24]
A PROGRESS REPORT ON THE TREATMENT OF 157 PATIENTS WITH ADVANCED CANCER USING LYMPHOKINE-ACTIVATED KILLER-CELLS AND INTERLEUKIN-2 OR HIGH-DOSE INTERLEUKIN-2 ALONE
ROSENBERG, SA
论文数:
0
引用数:
0
h-index:
0
机构:
NIH, CTR CLIN, BETHESDA, MD 20892 USA
NIH, CTR CLIN, BETHESDA, MD 20892 USA
ROSENBERG, SA
LOTZE, MT
论文数:
0
引用数:
0
h-index:
0
机构:
NIH, CTR CLIN, BETHESDA, MD 20892 USA
NIH, CTR CLIN, BETHESDA, MD 20892 USA
LOTZE, MT
MUUL, LM
论文数:
0
引用数:
0
h-index:
0
机构:
NIH, CTR CLIN, BETHESDA, MD 20892 USA
NIH, CTR CLIN, BETHESDA, MD 20892 USA
MUUL, LM
CHANG, AE
论文数:
0
引用数:
0
h-index:
0
机构:
NIH, CTR CLIN, BETHESDA, MD 20892 USA
NIH, CTR CLIN, BETHESDA, MD 20892 USA
CHANG, AE
AVIS, FP
论文数:
0
引用数:
0
h-index:
0
机构:
NIH, CTR CLIN, BETHESDA, MD 20892 USA
NIH, CTR CLIN, BETHESDA, MD 20892 USA
AVIS, FP
LEITMAN, S
论文数:
0
引用数:
0
h-index:
0
机构:
NIH, CTR CLIN, BETHESDA, MD 20892 USA
NIH, CTR CLIN, BETHESDA, MD 20892 USA
LEITMAN, S
LINEHAN, WM
论文数:
0
引用数:
0
h-index:
0
机构:
NIH, CTR CLIN, BETHESDA, MD 20892 USA
NIH, CTR CLIN, BETHESDA, MD 20892 USA
LINEHAN, WM
ROBERTSON, CN
论文数:
0
引用数:
0
h-index:
0
机构:
NIH, CTR CLIN, BETHESDA, MD 20892 USA
NIH, CTR CLIN, BETHESDA, MD 20892 USA
ROBERTSON, CN
LEE, RE
论文数:
0
引用数:
0
h-index:
0
机构:
NIH, CTR CLIN, BETHESDA, MD 20892 USA
NIH, CTR CLIN, BETHESDA, MD 20892 USA
LEE, RE
RUBIN, JT
论文数:
0
引用数:
0
h-index:
0
机构:
NIH, CTR CLIN, BETHESDA, MD 20892 USA
NIH, CTR CLIN, BETHESDA, MD 20892 USA
RUBIN, JT
SEIPP, CA
论文数:
0
引用数:
0
h-index:
0
机构:
NIH, CTR CLIN, BETHESDA, MD 20892 USA
NIH, CTR CLIN, BETHESDA, MD 20892 USA
SEIPP, CA
SIMPSON, CG
论文数:
0
引用数:
0
h-index:
0
机构:
NIH, CTR CLIN, BETHESDA, MD 20892 USA
NIH, CTR CLIN, BETHESDA, MD 20892 USA
SIMPSON, CG
WHITE, DE
论文数:
0
引用数:
0
h-index:
0
机构:
NIH, CTR CLIN, BETHESDA, MD 20892 USA
NIH, CTR CLIN, BETHESDA, MD 20892 USA
WHITE, DE
[J].
NEW ENGLAND JOURNAL OF MEDICINE,
1987,
316
(15)
: 889
-
897
[25]
OBSERVATIONS ON THE SYSTEMIC ADMINISTRATION OF AUTOLOGOUS LYMPHOKINE-ACTIVATED KILLER CELLS AND RECOMBINANT INTERLEUKIN-2 TO PATIENTS WITH METASTATIC CANCER
ROSENBERG, SA
论文数:
0
引用数:
0
h-index:
0
机构:
NIH,CTR CLIN,BETHESDA,MD 20205
NIH,CTR CLIN,BETHESDA,MD 20205
ROSENBERG, SA
LOTZE, MT
论文数:
0
引用数:
0
h-index:
0
机构:
NIH,CTR CLIN,BETHESDA,MD 20205
NIH,CTR CLIN,BETHESDA,MD 20205
LOTZE, MT
MUUL, LM
论文数:
0
引用数:
0
h-index:
0
机构:
NIH,CTR CLIN,BETHESDA,MD 20205
NIH,CTR CLIN,BETHESDA,MD 20205
MUUL, LM
LEITMAN, S
论文数:
0
引用数:
0
h-index:
0
机构:
NIH,CTR CLIN,BETHESDA,MD 20205
NIH,CTR CLIN,BETHESDA,MD 20205
LEITMAN, S
CHANG, AE
论文数:
0
引用数:
0
h-index:
0
机构:
NIH,CTR CLIN,BETHESDA,MD 20205
NIH,CTR CLIN,BETHESDA,MD 20205
CHANG, AE
ETTINGHAUSEN, SE
论文数:
0
引用数:
0
h-index:
0
机构:
NIH,CTR CLIN,BETHESDA,MD 20205
NIH,CTR CLIN,BETHESDA,MD 20205
ETTINGHAUSEN, SE
MATORY, YL
论文数:
0
引用数:
0
h-index:
0
机构:
NIH,CTR CLIN,BETHESDA,MD 20205
NIH,CTR CLIN,BETHESDA,MD 20205
MATORY, YL
SKIBBER, JM
论文数:
0
引用数:
0
h-index:
0
机构:
NIH,CTR CLIN,BETHESDA,MD 20205
NIH,CTR CLIN,BETHESDA,MD 20205
SKIBBER, JM
SHILONI, E
论文数:
0
引用数:
0
h-index:
0
机构:
NIH,CTR CLIN,BETHESDA,MD 20205
NIH,CTR CLIN,BETHESDA,MD 20205
SHILONI, E
VETTO, JT
论文数:
0
引用数:
0
h-index:
0
机构:
NIH,CTR CLIN,BETHESDA,MD 20205
NIH,CTR CLIN,BETHESDA,MD 20205
VETTO, JT
SEIPP, CA
论文数:
0
引用数:
0
h-index:
0
机构:
NIH,CTR CLIN,BETHESDA,MD 20205
NIH,CTR CLIN,BETHESDA,MD 20205
SEIPP, CA
SIMPSON, C
论文数:
0
引用数:
0
h-index:
0
机构:
NIH,CTR CLIN,BETHESDA,MD 20205
NIH,CTR CLIN,BETHESDA,MD 20205
SIMPSON, C
REICHERT, CM
论文数:
0
引用数:
0
h-index:
0
机构:
NIH,CTR CLIN,BETHESDA,MD 20205
NIH,CTR CLIN,BETHESDA,MD 20205
REICHERT, CM
[J].
NEW ENGLAND JOURNAL OF MEDICINE,
1985,
313
(23)
: 1485
-
1492
[26]
REGRESSION OF ESTABLISHED PULMONARY METASTASES AND SUBCUTANEOUS TUMOR MEDIATED BY THE SYSTEMIC ADMINISTRATION OF HIGH-DOSE RECOMBINANT INTERLEUKIN-2
ROSENBERG, SA
论文数:
0
引用数:
0
h-index:
0
机构:
NCI,PATHOL LAB,BETHESDA,MD 20205
NCI,PATHOL LAB,BETHESDA,MD 20205
ROSENBERG, SA
MULE, JJ
论文数:
0
引用数:
0
h-index:
0
机构:
NCI,PATHOL LAB,BETHESDA,MD 20205
NCI,PATHOL LAB,BETHESDA,MD 20205
MULE, JJ
SPIESS, PJ
论文数:
0
引用数:
0
h-index:
0
机构:
NCI,PATHOL LAB,BETHESDA,MD 20205
NCI,PATHOL LAB,BETHESDA,MD 20205
SPIESS, PJ
REICHERT, CM
论文数:
0
引用数:
0
h-index:
0
机构:
NCI,PATHOL LAB,BETHESDA,MD 20205
NCI,PATHOL LAB,BETHESDA,MD 20205
REICHERT, CM
SCHWARZ, SL
论文数:
0
引用数:
0
h-index:
0
机构:
NCI,PATHOL LAB,BETHESDA,MD 20205
NCI,PATHOL LAB,BETHESDA,MD 20205
SCHWARZ, SL
[J].
JOURNAL OF EXPERIMENTAL MEDICINE,
1985,
161
(05)
: 1169
-
1188
[27]
SONDEL PM, 1988, CANCER RES, V48, P2561
[28]
REPETITIVE WEEKLY CYCLES OF RECOMBINANT HUMAN INTERLEUKIN-2 - RESPONSES OF RENAL-CARCINOMA WITH ACCEPTABLE TOXICITY
SOSMAN, JA
论文数:
0
引用数:
0
h-index:
0
机构:
UNIV WISCONSIN,CTR CLIN SCI,600 HIGHLAND AVE,K4-448,MADISON,WI 53792
SOSMAN, JA
KOHLER, PC
论文数:
0
引用数:
0
h-index:
0
机构:
UNIV WISCONSIN,CTR CLIN SCI,600 HIGHLAND AVE,K4-448,MADISON,WI 53792
KOHLER, PC
HANK, J
论文数:
0
引用数:
0
h-index:
0
机构:
UNIV WISCONSIN,CTR CLIN SCI,600 HIGHLAND AVE,K4-448,MADISON,WI 53792
HANK, J
MOORE, KH
论文数:
0
引用数:
0
h-index:
0
机构:
UNIV WISCONSIN,CTR CLIN SCI,600 HIGHLAND AVE,K4-448,MADISON,WI 53792
MOORE, KH
BECHHOFER, R
论文数:
0
引用数:
0
h-index:
0
机构:
UNIV WISCONSIN,CTR CLIN SCI,600 HIGHLAND AVE,K4-448,MADISON,WI 53792
BECHHOFER, R
STORER, B
论文数:
0
引用数:
0
h-index:
0
机构:
UNIV WISCONSIN,CTR CLIN SCI,600 HIGHLAND AVE,K4-448,MADISON,WI 53792
STORER, B
SONDEL, PM
论文数:
0
引用数:
0
h-index:
0
机构:
UNIV WISCONSIN,CTR CLIN SCI,600 HIGHLAND AVE,K4-448,MADISON,WI 53792
SONDEL, PM
[J].
JOURNAL OF THE NATIONAL CANCER INSTITUTE,
1988,
80
(01)
: 60
-
63
[29]
HEMATOLOGIC REMISSION AND CYTOGENETIC IMPROVEMENT INDUCED BY RECOMBINANT HUMAN INTERFERON-ALPHA-A IN CHRONIC MYELOGENOUS LEUKEMIA
TALPAZ, M
论文数:
0
引用数:
0
h-index:
0
机构:
UNIV TEXAS,MD ANDERSON HOSP & TUMOR INST,CTR CANC,DEPT HEMATOL,HOUSTON,TX 77030
TALPAZ, M
KANTARJIAN, HM
论文数:
0
引用数:
0
h-index:
0
机构:
UNIV TEXAS,MD ANDERSON HOSP & TUMOR INST,CTR CANC,DEPT HEMATOL,HOUSTON,TX 77030
KANTARJIAN, HM
MCCREDIE, K
论文数:
0
引用数:
0
h-index:
0
机构:
UNIV TEXAS,MD ANDERSON HOSP & TUMOR INST,CTR CANC,DEPT HEMATOL,HOUSTON,TX 77030
MCCREDIE, K
TRUJILLO, JM
论文数:
0
引用数:
0
h-index:
0
机构:
UNIV TEXAS,MD ANDERSON HOSP & TUMOR INST,CTR CANC,DEPT HEMATOL,HOUSTON,TX 77030
TRUJILLO, JM
KEATING, MJ
论文数:
0
引用数:
0
h-index:
0
机构:
UNIV TEXAS,MD ANDERSON HOSP & TUMOR INST,CTR CANC,DEPT HEMATOL,HOUSTON,TX 77030
KEATING, MJ
GUTTERMAN, JU
论文数:
0
引用数:
0
h-index:
0
机构:
UNIV TEXAS,MD ANDERSON HOSP & TUMOR INST,CTR CANC,DEPT HEMATOL,HOUSTON,TX 77030
GUTTERMAN, JU
[J].
NEW ENGLAND JOURNAL OF MEDICINE,
1986,
314
(17)
: 1065
-
1069
[30]
IMMUNOTHERAPY OF A MURINE TUMOR WITH INTERLEUKIN-2 - INCREASED SENSITIVITY AFTER MHC CLASS-I GENE TRANSFECTION
WEBER, JS
论文数:
0
引用数:
0
h-index:
0
机构:
NCI,MOLEC VIROL LAB,BETHESDA,MD 20892
NCI,MOLEC VIROL LAB,BETHESDA,MD 20892
WEBER, JS
JAY, G
论文数:
0
引用数:
0
h-index:
0
机构:
NCI,MOLEC VIROL LAB,BETHESDA,MD 20892
NCI,MOLEC VIROL LAB,BETHESDA,MD 20892
JAY, G
TANAKA, K
论文数:
0
引用数:
0
h-index:
0
机构:
NCI,MOLEC VIROL LAB,BETHESDA,MD 20892
NCI,MOLEC VIROL LAB,BETHESDA,MD 20892
TANAKA, K
ROSENBERG, SA
论文数:
0
引用数:
0
h-index:
0
机构:
NCI,MOLEC VIROL LAB,BETHESDA,MD 20892
NCI,MOLEC VIROL LAB,BETHESDA,MD 20892
ROSENBERG, SA
[J].
JOURNAL OF EXPERIMENTAL MEDICINE,
1987,
166
(06)
: 1716
-
1733
←
1
2
3
→
共 30 条
[21]
ANTITUMOR-ACTIVITY OF RECOMBINANT-DERIVED INTERFERON-ALPHA IN METASTATIC RENAL-CELL CARCINOMA
QUESADA, JR
论文数:
0
引用数:
0
h-index:
0
机构:
UNIV TEXAS,MD ANDERSON HOSP & TUMOR INST,DEPT UROL,HOUSTON,TX 77030
QUESADA, JR
RIOS, A
论文数:
0
引用数:
0
h-index:
0
机构:
UNIV TEXAS,MD ANDERSON HOSP & TUMOR INST,DEPT UROL,HOUSTON,TX 77030
RIOS, A
SWANSON, D
论文数:
0
引用数:
0
h-index:
0
机构:
UNIV TEXAS,MD ANDERSON HOSP & TUMOR INST,DEPT UROL,HOUSTON,TX 77030
SWANSON, D
TROWN, P
论文数:
0
引用数:
0
h-index:
0
机构:
UNIV TEXAS,MD ANDERSON HOSP & TUMOR INST,DEPT UROL,HOUSTON,TX 77030
TROWN, P
GUTTERMAN, JU
论文数:
0
引用数:
0
h-index:
0
机构:
UNIV TEXAS,MD ANDERSON HOSP & TUMOR INST,DEPT UROL,HOUSTON,TX 77030
GUTTERMAN, JU
[J].
JOURNAL OF CLINICAL ONCOLOGY,
1985,
3
(11)
: 1522
-
1528
[22]
QUESADA JR, 1983, CANCER RES, V43, P940
[23]
TREATMENT OF HAIRY-CELL LEUKEMIA WITH RECOMBINANT ALPHA-INTERFERON
QUESADA, JR
论文数:
0
引用数:
0
h-index:
0
机构:
UNIV TEXAS,MD ANDERSON HOSP & TUMOR INST,DEPT PATHOL,HOUSTON,TX 77030
QUESADA, JR
HERSH, EM
论文数:
0
引用数:
0
h-index:
0
机构:
UNIV TEXAS,MD ANDERSON HOSP & TUMOR INST,DEPT PATHOL,HOUSTON,TX 77030
HERSH, EM
MANNING, J
论文数:
0
引用数:
0
h-index:
0
机构:
UNIV TEXAS,MD ANDERSON HOSP & TUMOR INST,DEPT PATHOL,HOUSTON,TX 77030
MANNING, J
REUBEN, J
论文数:
0
引用数:
0
h-index:
0
机构:
UNIV TEXAS,MD ANDERSON HOSP & TUMOR INST,DEPT PATHOL,HOUSTON,TX 77030
REUBEN, J
KEATING, M
论文数:
0
引用数:
0
h-index:
0
机构:
UNIV TEXAS,MD ANDERSON HOSP & TUMOR INST,DEPT PATHOL,HOUSTON,TX 77030
KEATING, M
SCHNIPPER, E
论文数:
0
引用数:
0
h-index:
0
机构:
UNIV TEXAS,MD ANDERSON HOSP & TUMOR INST,DEPT PATHOL,HOUSTON,TX 77030
SCHNIPPER, E
ITRI, L
论文数:
0
引用数:
0
h-index:
0
机构:
UNIV TEXAS,MD ANDERSON HOSP & TUMOR INST,DEPT PATHOL,HOUSTON,TX 77030
ITRI, L
GUTTERMAN, JU
论文数:
0
引用数:
0
h-index:
0
机构:
UNIV TEXAS,MD ANDERSON HOSP & TUMOR INST,DEPT PATHOL,HOUSTON,TX 77030
GUTTERMAN, JU
[J].
BLOOD,
1986,
68
(02)
: 493
-
497
[24]
A PROGRESS REPORT ON THE TREATMENT OF 157 PATIENTS WITH ADVANCED CANCER USING LYMPHOKINE-ACTIVATED KILLER-CELLS AND INTERLEUKIN-2 OR HIGH-DOSE INTERLEUKIN-2 ALONE
ROSENBERG, SA
论文数:
0
引用数:
0
h-index:
0
机构:
NIH, CTR CLIN, BETHESDA, MD 20892 USA
NIH, CTR CLIN, BETHESDA, MD 20892 USA
ROSENBERG, SA
LOTZE, MT
论文数:
0
引用数:
0
h-index:
0
机构:
NIH, CTR CLIN, BETHESDA, MD 20892 USA
NIH, CTR CLIN, BETHESDA, MD 20892 USA
LOTZE, MT
MUUL, LM
论文数:
0
引用数:
0
h-index:
0
机构:
NIH, CTR CLIN, BETHESDA, MD 20892 USA
NIH, CTR CLIN, BETHESDA, MD 20892 USA
MUUL, LM
CHANG, AE
论文数:
0
引用数:
0
h-index:
0
机构:
NIH, CTR CLIN, BETHESDA, MD 20892 USA
NIH, CTR CLIN, BETHESDA, MD 20892 USA
CHANG, AE
AVIS, FP
论文数:
0
引用数:
0
h-index:
0
机构:
NIH, CTR CLIN, BETHESDA, MD 20892 USA
NIH, CTR CLIN, BETHESDA, MD 20892 USA
AVIS, FP
LEITMAN, S
论文数:
0
引用数:
0
h-index:
0
机构:
NIH, CTR CLIN, BETHESDA, MD 20892 USA
NIH, CTR CLIN, BETHESDA, MD 20892 USA
LEITMAN, S
LINEHAN, WM
论文数:
0
引用数:
0
h-index:
0
机构:
NIH, CTR CLIN, BETHESDA, MD 20892 USA
NIH, CTR CLIN, BETHESDA, MD 20892 USA
LINEHAN, WM
ROBERTSON, CN
论文数:
0
引用数:
0
h-index:
0
机构:
NIH, CTR CLIN, BETHESDA, MD 20892 USA
NIH, CTR CLIN, BETHESDA, MD 20892 USA
ROBERTSON, CN
LEE, RE
论文数:
0
引用数:
0
h-index:
0
机构:
NIH, CTR CLIN, BETHESDA, MD 20892 USA
NIH, CTR CLIN, BETHESDA, MD 20892 USA
LEE, RE
RUBIN, JT
论文数:
0
引用数:
0
h-index:
0
机构:
NIH, CTR CLIN, BETHESDA, MD 20892 USA
NIH, CTR CLIN, BETHESDA, MD 20892 USA
RUBIN, JT
SEIPP, CA
论文数:
0
引用数:
0
h-index:
0
机构:
NIH, CTR CLIN, BETHESDA, MD 20892 USA
NIH, CTR CLIN, BETHESDA, MD 20892 USA
SEIPP, CA
SIMPSON, CG
论文数:
0
引用数:
0
h-index:
0
机构:
NIH, CTR CLIN, BETHESDA, MD 20892 USA
NIH, CTR CLIN, BETHESDA, MD 20892 USA
SIMPSON, CG
WHITE, DE
论文数:
0
引用数:
0
h-index:
0
机构:
NIH, CTR CLIN, BETHESDA, MD 20892 USA
NIH, CTR CLIN, BETHESDA, MD 20892 USA
WHITE, DE
[J].
NEW ENGLAND JOURNAL OF MEDICINE,
1987,
316
(15)
: 889
-
897
[25]
OBSERVATIONS ON THE SYSTEMIC ADMINISTRATION OF AUTOLOGOUS LYMPHOKINE-ACTIVATED KILLER CELLS AND RECOMBINANT INTERLEUKIN-2 TO PATIENTS WITH METASTATIC CANCER
ROSENBERG, SA
论文数:
0
引用数:
0
h-index:
0
机构:
NIH,CTR CLIN,BETHESDA,MD 20205
NIH,CTR CLIN,BETHESDA,MD 20205
ROSENBERG, SA
LOTZE, MT
论文数:
0
引用数:
0
h-index:
0
机构:
NIH,CTR CLIN,BETHESDA,MD 20205
NIH,CTR CLIN,BETHESDA,MD 20205
LOTZE, MT
MUUL, LM
论文数:
0
引用数:
0
h-index:
0
机构:
NIH,CTR CLIN,BETHESDA,MD 20205
NIH,CTR CLIN,BETHESDA,MD 20205
MUUL, LM
LEITMAN, S
论文数:
0
引用数:
0
h-index:
0
机构:
NIH,CTR CLIN,BETHESDA,MD 20205
NIH,CTR CLIN,BETHESDA,MD 20205
LEITMAN, S
CHANG, AE
论文数:
0
引用数:
0
h-index:
0
机构:
NIH,CTR CLIN,BETHESDA,MD 20205
NIH,CTR CLIN,BETHESDA,MD 20205
CHANG, AE
ETTINGHAUSEN, SE
论文数:
0
引用数:
0
h-index:
0
机构:
NIH,CTR CLIN,BETHESDA,MD 20205
NIH,CTR CLIN,BETHESDA,MD 20205
ETTINGHAUSEN, SE
MATORY, YL
论文数:
0
引用数:
0
h-index:
0
机构:
NIH,CTR CLIN,BETHESDA,MD 20205
NIH,CTR CLIN,BETHESDA,MD 20205
MATORY, YL
SKIBBER, JM
论文数:
0
引用数:
0
h-index:
0
机构:
NIH,CTR CLIN,BETHESDA,MD 20205
NIH,CTR CLIN,BETHESDA,MD 20205
SKIBBER, JM
SHILONI, E
论文数:
0
引用数:
0
h-index:
0
机构:
NIH,CTR CLIN,BETHESDA,MD 20205
NIH,CTR CLIN,BETHESDA,MD 20205
SHILONI, E
VETTO, JT
论文数:
0
引用数:
0
h-index:
0
机构:
NIH,CTR CLIN,BETHESDA,MD 20205
NIH,CTR CLIN,BETHESDA,MD 20205
VETTO, JT
SEIPP, CA
论文数:
0
引用数:
0
h-index:
0
机构:
NIH,CTR CLIN,BETHESDA,MD 20205
NIH,CTR CLIN,BETHESDA,MD 20205
SEIPP, CA
SIMPSON, C
论文数:
0
引用数:
0
h-index:
0
机构:
NIH,CTR CLIN,BETHESDA,MD 20205
NIH,CTR CLIN,BETHESDA,MD 20205
SIMPSON, C
REICHERT, CM
论文数:
0
引用数:
0
h-index:
0
机构:
NIH,CTR CLIN,BETHESDA,MD 20205
NIH,CTR CLIN,BETHESDA,MD 20205
REICHERT, CM
[J].
NEW ENGLAND JOURNAL OF MEDICINE,
1985,
313
(23)
: 1485
-
1492
[26]
REGRESSION OF ESTABLISHED PULMONARY METASTASES AND SUBCUTANEOUS TUMOR MEDIATED BY THE SYSTEMIC ADMINISTRATION OF HIGH-DOSE RECOMBINANT INTERLEUKIN-2
ROSENBERG, SA
论文数:
0
引用数:
0
h-index:
0
机构:
NCI,PATHOL LAB,BETHESDA,MD 20205
NCI,PATHOL LAB,BETHESDA,MD 20205
ROSENBERG, SA
MULE, JJ
论文数:
0
引用数:
0
h-index:
0
机构:
NCI,PATHOL LAB,BETHESDA,MD 20205
NCI,PATHOL LAB,BETHESDA,MD 20205
MULE, JJ
SPIESS, PJ
论文数:
0
引用数:
0
h-index:
0
机构:
NCI,PATHOL LAB,BETHESDA,MD 20205
NCI,PATHOL LAB,BETHESDA,MD 20205
SPIESS, PJ
REICHERT, CM
论文数:
0
引用数:
0
h-index:
0
机构:
NCI,PATHOL LAB,BETHESDA,MD 20205
NCI,PATHOL LAB,BETHESDA,MD 20205
REICHERT, CM
SCHWARZ, SL
论文数:
0
引用数:
0
h-index:
0
机构:
NCI,PATHOL LAB,BETHESDA,MD 20205
NCI,PATHOL LAB,BETHESDA,MD 20205
SCHWARZ, SL
[J].
JOURNAL OF EXPERIMENTAL MEDICINE,
1985,
161
(05)
: 1169
-
1188
[27]
SONDEL PM, 1988, CANCER RES, V48, P2561
[28]
REPETITIVE WEEKLY CYCLES OF RECOMBINANT HUMAN INTERLEUKIN-2 - RESPONSES OF RENAL-CARCINOMA WITH ACCEPTABLE TOXICITY
SOSMAN, JA
论文数:
0
引用数:
0
h-index:
0
机构:
UNIV WISCONSIN,CTR CLIN SCI,600 HIGHLAND AVE,K4-448,MADISON,WI 53792
SOSMAN, JA
KOHLER, PC
论文数:
0
引用数:
0
h-index:
0
机构:
UNIV WISCONSIN,CTR CLIN SCI,600 HIGHLAND AVE,K4-448,MADISON,WI 53792
KOHLER, PC
HANK, J
论文数:
0
引用数:
0
h-index:
0
机构:
UNIV WISCONSIN,CTR CLIN SCI,600 HIGHLAND AVE,K4-448,MADISON,WI 53792
HANK, J
MOORE, KH
论文数:
0
引用数:
0
h-index:
0
机构:
UNIV WISCONSIN,CTR CLIN SCI,600 HIGHLAND AVE,K4-448,MADISON,WI 53792
MOORE, KH
BECHHOFER, R
论文数:
0
引用数:
0
h-index:
0
机构:
UNIV WISCONSIN,CTR CLIN SCI,600 HIGHLAND AVE,K4-448,MADISON,WI 53792
BECHHOFER, R
STORER, B
论文数:
0
引用数:
0
h-index:
0
机构:
UNIV WISCONSIN,CTR CLIN SCI,600 HIGHLAND AVE,K4-448,MADISON,WI 53792
STORER, B
SONDEL, PM
论文数:
0
引用数:
0
h-index:
0
机构:
UNIV WISCONSIN,CTR CLIN SCI,600 HIGHLAND AVE,K4-448,MADISON,WI 53792
SONDEL, PM
[J].
JOURNAL OF THE NATIONAL CANCER INSTITUTE,
1988,
80
(01)
: 60
-
63
[29]
HEMATOLOGIC REMISSION AND CYTOGENETIC IMPROVEMENT INDUCED BY RECOMBINANT HUMAN INTERFERON-ALPHA-A IN CHRONIC MYELOGENOUS LEUKEMIA
TALPAZ, M
论文数:
0
引用数:
0
h-index:
0
机构:
UNIV TEXAS,MD ANDERSON HOSP & TUMOR INST,CTR CANC,DEPT HEMATOL,HOUSTON,TX 77030
TALPAZ, M
KANTARJIAN, HM
论文数:
0
引用数:
0
h-index:
0
机构:
UNIV TEXAS,MD ANDERSON HOSP & TUMOR INST,CTR CANC,DEPT HEMATOL,HOUSTON,TX 77030
KANTARJIAN, HM
MCCREDIE, K
论文数:
0
引用数:
0
h-index:
0
机构:
UNIV TEXAS,MD ANDERSON HOSP & TUMOR INST,CTR CANC,DEPT HEMATOL,HOUSTON,TX 77030
MCCREDIE, K
TRUJILLO, JM
论文数:
0
引用数:
0
h-index:
0
机构:
UNIV TEXAS,MD ANDERSON HOSP & TUMOR INST,CTR CANC,DEPT HEMATOL,HOUSTON,TX 77030
TRUJILLO, JM
KEATING, MJ
论文数:
0
引用数:
0
h-index:
0
机构:
UNIV TEXAS,MD ANDERSON HOSP & TUMOR INST,CTR CANC,DEPT HEMATOL,HOUSTON,TX 77030
KEATING, MJ
GUTTERMAN, JU
论文数:
0
引用数:
0
h-index:
0
机构:
UNIV TEXAS,MD ANDERSON HOSP & TUMOR INST,CTR CANC,DEPT HEMATOL,HOUSTON,TX 77030
GUTTERMAN, JU
[J].
NEW ENGLAND JOURNAL OF MEDICINE,
1986,
314
(17)
: 1065
-
1069
[30]
IMMUNOTHERAPY OF A MURINE TUMOR WITH INTERLEUKIN-2 - INCREASED SENSITIVITY AFTER MHC CLASS-I GENE TRANSFECTION
WEBER, JS
论文数:
0
引用数:
0
h-index:
0
机构:
NCI,MOLEC VIROL LAB,BETHESDA,MD 20892
NCI,MOLEC VIROL LAB,BETHESDA,MD 20892
WEBER, JS
JAY, G
论文数:
0
引用数:
0
h-index:
0
机构:
NCI,MOLEC VIROL LAB,BETHESDA,MD 20892
NCI,MOLEC VIROL LAB,BETHESDA,MD 20892
JAY, G
TANAKA, K
论文数:
0
引用数:
0
h-index:
0
机构:
NCI,MOLEC VIROL LAB,BETHESDA,MD 20892
NCI,MOLEC VIROL LAB,BETHESDA,MD 20892
TANAKA, K
ROSENBERG, SA
论文数:
0
引用数:
0
h-index:
0
机构:
NCI,MOLEC VIROL LAB,BETHESDA,MD 20892
NCI,MOLEC VIROL LAB,BETHESDA,MD 20892
ROSENBERG, SA
[J].
JOURNAL OF EXPERIMENTAL MEDICINE,
1987,
166
(06)
: 1716
-
1733
←
1
2
3
→